Roles of the Caspase-11 Non-Canonical Inflammasome in Rheumatic Diseases

• Published in: International journal of molecular sciences 2024-02, Vol.25 (4), p.2091
• Main Author: Yi, Young-Su
• Format: Article
• Language: English
• Subjects: Animals; Arthritis, Rheumatoid; Caspase 1 - metabolism; caspase-11; caspase-4; Caspases - metabolism; Cell death; Connective tissue; Cooperation; Cytokines; Development and progression; Gram-negative bacteria; Humans; Immune system; inflammasome; Inflammasomes - metabolism; Inflammation; Mice; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein - metabolism; non-canonical inflammasome; Osteoarthritis; Pathogenesis; Potassium; Psoriasis; rheumatic disease; Rheumatic Diseases; Rheumatoid arthritis; Rheumatoid factor; Roles; Systemic lupus erythematosus
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25042091

Inflammasomes are intracellular multiprotein complexes that activate inflammatory signaling pathways. Inflammasomes comprise two major classes: canonical inflammasomes, which were discovered first and are activated in response to a variety of pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), and non-canonical inflammasomes, which were discovered recently and are only activated in response to intracellular lipopolysaccharide (LPS). Although a larger number of studies have successfully demonstrated that canonical inflammasomes, particularly the NLRP3 inflammasome, play roles in various rheumatic diseases, including rheumatoid arthritis (RA), infectious arthritis (IR), gouty arthritis (GA), osteoarthritis (OA), systemic lupus erythematosus (SLE), psoriatic arthritis (PA), ankylosing spondylitis (AS), and Sjögren's syndrome (SjS), the regulatory roles of non-canonical inflammasomes, such as mouse caspase-11 and human caspase-4 non-canonical inflammasomes, in these diseases are still largely unknown. Interestingly, an increasing number of studies have reported possible roles for non-canonical inflammasomes in the pathogenesis of various mouse models of rheumatic disease. This review comprehensively summarizes and discusses recent emerging studies demonstrating the regulatory roles of non-canonical inflammasomes, particularly focusing on the caspase-11 non-canonical inflammasome, in the pathogenesis and progression of various types of rheumatic diseases and provides new insights into strategies for developing potential therapeutics to prevent and treat rheumatic diseases as well as associated diseases by targeting non-canonical inflammasomes.